 | Atosiban, sold under the brand name Tractocile among others, is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication... 18 KB (1,722 words) - 16:33, 19 December 2023 |
Calcium-channel blockers (such as nifedipine) and oxytocin antagonists (such as atosiban) may delay delivery by 2 to 7 days, depending on how quickly the medication... 31 KB (2,484 words) - 04:47, 19 February 2024 |
 | smooth muscle to delay premature labor. While preferred over agents such as atosiban and ritodrine, its role has largely been replaced by the calcium channel... 34 KB (2,905 words) - 05:05, 12 May 2024 |
 | beta-agonists and may also have some benefits over atosiban and magnesium sulfate, although atosiban results in fewer maternal adverse effects. No difference... 26 KB (2,347 words) - 03:16, 18 April 2024 |
 | to facilitate birth and to stimulate milk release. The tocolytic agent atosiban (Tractocile) acts as an antagonist of oxytocin receptors. It is registered... 34 KB (3,243 words) - 19:40, 29 April 2024 |
 | Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 17 KB (1,518 words) - 18:20, 7 November 2023 |
 | Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 43 KB (3,871 words) - 10:12, 24 March 2024 |
| gland Target tissues Wide spread Receptors Oxytocin receptor Antagonists Atosiban Precursor Oxytocin/neurophysin I prepropeptide Metabolism Liver and other... 105 KB (11,781 words) - 06:45, 27 April 2024 |
 | the induction of labour; Endometrin / Lutinus (progesterone) Tractocile (atosiban), to delay premature labor Pabal/ Duratocin/ Lonactene / Duratobal / (carbetocin)... 18 KB (1,712 words) - 13:07, 5 March 2024 |
| Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 3 KB (264 words) - 09:37, 6 July 2023 |
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 3 KB (407 words) - 06:08, 27 March 2022 |
 | increase the clinical pregnancy rate compared with no antibiotics. The use of Atosiban, G-CSF and hCG around the time of embryo transfer showed a trend towards... 46 KB (5,596 words) - 03:13, 14 April 2024 |
 | Cesarean section. Oxytocin receptor antagonists, such as barusiban or atosiban have the opposite effect of depressing oxytocin receptor activity and can... 21 KB (1,913 words) - 05:27, 3 February 2024 |
agonist or as a uterotonic. Some may oppose uterine contractility such as atosiban. Carbetocin: A long-acting synthetic analog with a half-life 4 to 10 times... 20 KB (2,344 words) - 03:55, 27 December 2023 |
 | Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 11 KB (763 words) - 09:26, 13 August 2023 |
 | Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 8 KB (691 words) - 17:41, 5 July 2023 |
 | Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 90 KB (9,543 words) - 09:52, 10 May 2024 |
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 3 KB (209 words) - 22:17, 3 December 2023 |
| Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 25 KB (2,496 words) - 15:39, 20 December 2023 |
 | oxytocinergic signalling in mediating these important social behaviours. Atosiban Barusiban Epelsiban L-371,257 Retosiban Williams PD, Anderson PS, Ball... 4 KB (304 words) - 13:03, 29 January 2023 |
 | Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 15 KB (1,714 words) - 20:29, 11 March 2024 |
 | Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 8 KB (805 words) - 10:03, 9 December 2022 |
Ibuprofen G02CC02 Naproxen G02CC03 Benzydamine G02CC04 Flunoxaprofen G02CX01 Atosiban G02CX02 Flibanserin G02CX03 Agni casti fructus G02CX04 Cimicifugae rhizoma... 2 KB (301 words) - 01:47, 31 December 2022 |
 | anxiolytic in mice; possibly non-selective over vasopressin receptors Peptide Atosiban Barusiban Non-peptide Epelsiban L-368,899 (CAS# 148927-60-0) L-371,257... 22 KB (2,492 words) - 08:21, 9 May 2024 |
 | anti-inflammatory drugs, calcium channel blockers, beta mimetics, and atosiban. Tocolysis rarely delays delivery beyond 24–48 hours. This delay, however... 168 KB (19,070 words) - 00:15, 8 May 2024 |
 | Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 10 KB (584 words) - 08:21, 8 March 2024 |
 | Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 5 KB (231 words) - 11:13, 1 June 2023 |
| Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 27 KB (2,458 words) - 20:56, 1 May 2024 |
Non-peptide: CA7 LIT-001 TC OT 39 WAY-267464 WJ0679 Antagonists: Peptide: Atosiban Tocinoic acid; Non-peptide: Barusiban Cligosiban Epelsiban Erlosiban IX-01... 11 KB (974 words) - 03:10, 10 March 2024 |
 | vasopressin receptors. It is also 100-fold more potent at the hOTR than atosiban (a marketed intravenous peptide oxytocin antagonist) and is 5-fold more... 15 KB (1,682 words) - 16:38, 19 December 2023 |